Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy. [electronic resource]
- Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons Apr 2016
- 738-46 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
1531-5053
10.1016/j.joms.2015.09.028 doi
Administration, Intravenous Aged Alkaline Phosphatase--blood Angiogenic Proteins--blood Biomarkers--blood Bisphosphonate-Associated Osteonecrosis of the Jaw--blood Bone Density Conservation Agents--administration & dosage Bone and Bones--metabolism C-Reactive Protein--analysis Case-Control Studies Collagen Type I--blood Diphosphonates--administration & dosage Female Humans Inflammation Mediators--blood Male Middle Aged Osteocalcin--blood Peptides--blood Thyrotropin--blood Thyroxine--blood Triiodothyronine--blood Vascular Endothelial Growth Factor A--blood Vitamin D--analogs & derivatives